The IPO Buzz
IPO Calendar
Last Week's IPO Traffic
Pricings
2015 Pricings
Last 100 IPOs
Last 12 Months
IPOs by Managers
By Industry
Secondary Offerings
IPO Pipeline
SCOOP Ratings
IPOs Recently Filed
IPOs by Managers
By Industry
Secondary Offerings
Archives
SCOOP Track Record From 2000 to Present
IPO Traffic by Week
IPO Index
Invitae 
General Information
Business: Invitae's mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Our goal is to aggregate most of the world's genetic tests into a single service with higher quality, faster turnaround time and lower price than many single gene tests today. We were founded on four core principles:
• Patients should own and control their own genetic information;
• Healthcare professionals are fundamental in ordering and interpreting genetic information;
• Genetic information is more valuable when shared; and
• Driving down the price of genetic information will increase its clinical and personal utility.
Industry: MEDICAL LABORATORIES
Employees: 161 Founded: 2010
Contact Information
Address: 458 Brannan Street, San Francisco, CA 94107, US
Phone: (415) 374–7782
Web Address: www.invitae.com
View Prospectus: Invitae
Financial Information
Market Cap: $ 417.2 mil
Revenues: $ 0.8 mil (last 12 months)
Net Income: $ -40.3 mil (last 12 months)
IPO Profile
Symbol: NVTA
Shares (millions): 6.4
Price Range: $16.00 - $16.00
Est.$ Volume $ 101.6 mil
Manager / Joint Managers J.P. Morgan
Co Managers Cowen and Company/ Leerink Partners
Expected to Trade 2/12/2015
Status Priced
SCOOP RATING Available only to Subscribers
RATING CHANGE Available only to Subscribers


 
© 2024 IPOSCOOP.com All rights reserved.